- Home
- ACIU vs FBLA Comparison
ACIU vs FBLA Comparison
Compare ACIU & FBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FBLA
- Stock Information
- Founded
- ACIU 2003
- FBLA 1908
- Country
- ACIU Switzerland
- FBLA United States
- Employees
- ACIU N/A
- FBLA N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FBLA
- Sector
- ACIU Health Care
- FBLA
- Exchange
- ACIU Nasdaq
- FBLA NYSE
- Market Cap
- ACIU 247.4M
- FBLA 227.1M
- IPO Year
- ACIU 2016
- FBLA N/A
- Fundamental
- Price
- ACIU $1.98
- FBLA $11.25
- Analyst Decision
- ACIU Strong Buy
- FBLA
- Analyst Count
- ACIU 2
- FBLA 0
- Target Price
- ACIU $12.00
- FBLA N/A
- AVG Volume (30 Days)
- ACIU 197.4K
- FBLA 81.0K
- Earning Date
- ACIU 03-13-2025
- FBLA 01-01-0001
- Dividend Yield
- ACIU N/A
- FBLA N/A
- EPS Growth
- ACIU N/A
- FBLA N/A
- EPS
- ACIU N/A
- FBLA N/A
- Revenue
- ACIU $30,136,397.00
- FBLA $64,935,000.00
- Revenue This Year
- ACIU $120.91
- FBLA N/A
- Revenue Next Year
- ACIU $13.82
- FBLA N/A
- P/E Ratio
- ACIU N/A
- FBLA N/A
- Revenue Growth
- ACIU 84.51
- FBLA N/A
- 52 Week Low
- ACIU $1.95
- FBLA $10.74
- 52 Week High
- ACIU $4.98
- FBLA $12.74
- Technical
- Relative Strength Index (RSI)
- ACIU 27.05
- FBLA N/A
- Support Level
- ACIU $1.95
- FBLA N/A
- Resistance Level
- ACIU $2.05
- FBLA N/A
- Average True Range (ATR)
- ACIU 0.13
- FBLA 0.00
- MACD
- ACIU -0.02
- FBLA 0.00
- Stochastic Oscillator
- ACIU 6.38
- FBLA 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.